ArticleJournal of cosmetic dermatology2025
Micro-Focused Ultrasound Treatment for Periocular Skin Leading to Corneal Leukoma With Iridocyclitis: A Case Report.
Article in Journal of cosmetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMicro-focused ultrasound (MFUS) converts the mechanical energy of high-frequency vibrations into thermal energy and induces collagen remodeling through thermal effects to achieve skin tightening and lifting. However, when employed for periocular skin treatment, MFUS carries a potential risk of ocular injury, which deserves high attention from cosmetic surgeons.
aimsThis article reports a case of a young female patient who developed transient visual acuity decline with iridocyclitis and residual corneal leukoma after MFUS treatment on the periocular skin. PATIENT: A 32-year-old female patient underwent facial MFUS treatment at a cosmetic clinic to improve facial skin laxity. During the treatment of the right periocular skin, the patient developed right eye pain and visual acuity decline. The patient was treated with nonsteroidal anti-inflammatory drugs (NSAIDs) and glucocorticoids in the right eye and followed up for 3 months. The visual acuity of the right eye improved, but a permanent corneal leukoma persisted.
resultsWhile MFUS treatment targeting the periorbital area can improve skin laxity, it poses a risk of corneal injury and iridocyclitis. After the treatment, the iridocyclitis resolved, but a permanent corneal leukoma remained.
conclusionsPeriocular MFUS treatment carries the risk of irreversible thermal damage to ocular tissues. Cosmetic surgeons must strictly determine the intensity threshold for periocular MFUS and ensure proper application of eye-protective devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.